Skip to main content
Wockhardt Ltd logo

Wockhardt Ltd — Investor Relations & Filings

Ticker · WOCKPHARMA ISIN · INE049B01025 LEI · 3358001OC2OX7OZAHZ33 BSE.NS Manufacturing
Open in API
Filings indexed 861 across all filing types
Latest filing 2021-03-24 Regulatory Filings
Country IN India
Listing BSE.NS WOCKPHARMA

About Wockhardt Ltd

https://www.wockhardt.com/

Wockhardt Ltd is a research-driven global organization focused on the development and manufacturing of formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company maintains a specialized focus on drug discovery, particularly in the field of anti-infectives and New Chemical Entities (NCEs) aimed at addressing antimicrobial resistance. Its therapeutic portfolio encompasses diverse areas such as diabetes, nephrology, cardiology, and respiratory health. With a strong emphasis on research and development, the company operates multiple manufacturing facilities that comply with international regulatory standards. Wockhardt provides medical solutions across various international markets, utilizing its expertise in complex chemistry and biotechnology to address unmet clinical needs.

Recent filings

Filing Released Lang Actions
Board Meeting — Board meeting Rescheduled
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the postponement of a meeting of the Credit Facilities Committee of the Board of Directors, originally scheduled to consider raising funds through issuance of Nonconvertible Debentures. It also mentions the reopening of the trading window for designated persons. There is no financial data, no detailed report, no voting results, no management discussion, and no presentation. The document is an announcement related to a board committee meeting and financing plans but does not provide substantive financing details or results. Given the short length (1576 characters) and the nature of the content (postponement notice), it fits best as a Regulatory Filing (RNS) rather than a Capital/Financing Update (CAP) because it does not provide an update on financing activities but only postpones a meeting related to such activities.
2021-03-24 English
Trading Window
Capital/Financing Update Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding a scheduled meeting of the Credit Facilities Committee of the Board of Directors to consider raising funds through issuance of Non-convertible Debentures. It also includes information about the trading window closure period. The document references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings and capital raising activities. The content is an announcement about a financing activity and not the actual detailed report or financial statements. The document length is short (1371 characters), and it does not contain financial data or detailed analysis, so it is not a full Capital/Financing Update report but rather an announcement related to financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-03-21 English
Board Meeting — Fund Raising
Capital/Financing Update Classification · 95% confidence The document is a notification pursuant to SEBI regulations about a scheduled meeting of the Credit Facilities Committee to consider raising funds through issuance of Non-convertible Debentures on a private placement basis. It also mentions the closure of the trading window for insiders. The document is short (1371 characters) and serves as an announcement of a financing activity rather than a detailed report or financial statement. It does not contain financial data or results but informs about upcoming capital raising plans. Therefore, it fits the category of Capital/Financing Update (CAP).
2021-03-21 English
Allotment of Securities
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of equity shares following the exercise of employee stock options. It specifies the increase in paid-up equity share capital and confirms the ranking of the new shares pari-passu with existing shares. There is no financial data, report, or detailed analysis present. The document is an announcement about a capital change (share allotment) rather than a full report or financial statement. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short and focused solely on this announcement, confirming the classification.
2021-03-09 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated 10th February 2021 from Wockhardt Limited announcing the extension of a COVID-19 vaccination contract with the UK Government. It is addressed to stock exchanges and contains no financial statements, regulatory filings, or detailed financial data. The content is a corporate announcement about a contract extension, not a financial report or regulatory filing. It is not an earnings release or capital update but a general corporate news announcement. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-02-10 English
Copy of Newspaper Publication
Regulatory Filings
2021-01-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.